Header Logo

Connection

THOMAS KOSTEN to Celecoxib

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Celecoxib.
THOMAS KOSTEN
Connection Strength
0.052
Celecoxib
  1. A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-na?ve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms. Neuropsychopharmacology. 2024 Apr; 49(5):893-902.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.